drugset / Trial / NCT06289335

Dexmedetomidine Compared to Ondansetron for Postanaesthetic Shivering in Patients Undergoing a Cesarean Section

NCT06289335

Phase 2 Completed 40 enrolled Hospital Central "Dr. Ignacio Morones Prieto"
RandomizedParallel-groupSingle-blindTreatment

Summary

Evaluate the efficiency of management with intravenous dexmedetomidine compared to intravenous ondansetron to achieve the disappearance of post-anesthetic shivering in a shorter time in the obstetric patient undergoing cesarean section under regional anesthesia.

Timeline

Start
2020-08-05
Primary completion
2021-09-05
Completion
2022-01-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.3 ug/kg Intravenous
Subject Ondansetron Other / unclassified 8 mg Intravenous

Indications

No indication recorded.